MRI-Based Scoring Method Differentiates IMCC from Solitary Colorectal Liver Metastasis

Overview

This study developed a practical MRI-based scoring system to differentiate intrahepatic mass-forming cholangiocarcinoma (IMCC) from solitary colorectal liver metastasis (CRLM). Using qualitative and quantitative MRI features, the scoring method aids radiologists and clinicians in distinguishing these hypoenhancing liver lesions, which have overlapping imaging characteristics but require different management.

Background

Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver malignancy, with the mass-forming subtype being the most frequent. Colorectal liver metastases (CRLM) are the most common liver metastases and often present as solitary lesions, which can mimic IMCC on imaging. Both lesions typically appear hypoenhancing with a hyperenhancing rim on MRI, complicating differentiation. Accurate distinction is critical as treatment strategies differ significantly between IMCC and CRLM.

Data Highlights

The study retrospectively included patients with pathologically confirmed IMCC or solitary CRLM from two hospitals, using a training cohort (hospital 1) and a validation cohort (hospital 2). MRI qualitative features assessed included lesion shape, margin, intensity heterogeneity, enhancement patterns, and presence of bile duct dilatation or capsular retraction. Quantitative analysis involved lesion-to-liver contrast ratios across multiple MRI phases and measurement of arterial phase rim thickness and lesion size. Interobserver agreement was evaluated, and discrepancies resolved by a senior radiologist.

Key Findings

• IMCC and solitary CRLM share overlapping MRI features, including hypoenhancement with a hyperenhancing rim, complicating differentiation.
• Specific MRI qualitative features such as lesion shape, margin smoothness, presence of peritumoral bile duct dilatation, and hepatic capsular retraction were identified as differentiating factors.
• Quantitative measures like lesion-to-liver contrast ratios and arterial phase rim thickness contributed to distinguishing IMCC from CRLM.
• The developed scoring system integrates these MRI features to provide a practical diagnostic tool for differentiating IMCC from solitary CRLM.
• Interobserver agreement was assessed to ensure reliability of MRI feature evaluation.

Clinical Implications

The MRI-based scoring system offers clinicians a noninvasive, practical approach to differentiate IMCC from solitary CRLM, facilitating appropriate treatment planning. Early and accurate diagnosis can guide surgical decisions and chemotherapy strategies, improving patient outcomes. Radiologists should incorporate both qualitative and quantitative MRI features when evaluating solitary hypoenhancing liver lesions in patients with or without known colorectal cancer.

Conclusion

This study presents a validated MRI scoring method that effectively differentiates intrahepatic mass-forming cholangiocarcinoma from solitary colorectal liver metastasis. The tool enhances diagnostic confidence and supports tailored management of these distinct hepatic malignancies.

References

1. Zhang et al. 2022 -- A Practical Scoring Method for Differentiating IMCC from Isolated CRLM Using MRI